Long-term impact of the 10-valent pneumococcal conjugate vaccine on nonvaccine pneumococcal serotypes: implications for practice and surveillance
Marcos Brum, Luiza Fernandes Xavier, Gabriela Bastian, Paula Barros de Barros, Eduardo Herter, Marina Pietá, Camila Machado, Frederico Friedrich, Marcelo C Scotta, Leonardo Araujo Pinto · 2025
Read Long-term impact of the 10-valent pneumococcal conjugate vaccine on nonvaccine pneumococcal serotypes: implications for practice and surveillance by Marcos Brum, Luiza Fernandes Xavier, Gabriela Bastian, Paula Barros de Barros, Eduardo Herter, Marina Pietá, Camila Machado, Frederico Friedrich, Marcelo C Scotta, Leonardo Araujo Pinto (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13143788.txt.
Description
Marcos Brum and colleagues assessed long-term effects of the 10-valent pneumococcal vaccine in Brazil. Their 2025 paper tracks nonvaccine serotypes after rollout. Pneumonia kills hundreds of thousands of young children yearly worldwide. Pneumococcus is the bacterium most often blamed. Brazil added the ten-valent vaccine to its program in 2010.
That vaccine omits serotype 19A, a known disease causer. Replacement by nonvaccine types is the worry after mass vaccination. Years of follow-up let the team judge that shift. Children with heart or lung conditions face the highest risk. Serotype patterns in disease cases were charted over time. Findings inform whether broader vaccines should take over. Public programs need such long-range checks on their choices.
Catalog record
| CREATOR | Marcos Brum, Luiza Fernandes Xavier, Gabriela Bastian, Paula Barros de Barros, Eduardo Herter, Marina Pietá, Camila Machado, Frederico Friedrich, Marcelo C Scotta, Leonardo Araujo Pinto |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 7 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |